This enabled Victor Macarrón-Palacios to investigate the neural cytoskeleton in his doctoral thesis. These discoveries were further complemented by biochemical techniques and the expertise and ...

Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune system functions poorly. It is made from human blood plasma and is ...

Yet studies have shown that patients with primary immunodeficiencies including patients receiving intravenous immunoglobulin (IVIG) treatment who have been vaccinated against COVID-19 experience ...

Nobile-Orazio and colleagues (2012) compared two of the more commonly used therapies for CIDP: IV immunoglobulin (IVIg) and IV methylprednisolone. The authors performed a multicenter, randomized ...

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

If you are immunocompromised and exposed to measles, Primeggia advises you contact your doctor or the health department because you may be eligible for intravenous immune globulin (IVIG). Expect to ...

Details and references regarding individual diseases are provided in the Supplementary Appendix. CIDP denotes chronic inflammatory demyelinating polyneuropathy, Covid-19 coronavirus disease 2019 ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer.

The effect of intravenous immunoglobulin (IVIg) treatment was studied in five patients with lower motor neuron disease associated with highly raised anti-GM1 antibodies but without evidence of ...

10 Central and Peripheral Degenerative Neuropathy Unit, IRCCS Foundation, Carlo Besta Neurological Institute, Milan, Italy Background We reported that 6-month therapy with intravenous immunoglobulin ...

sickkids.ca Intravenous immunoglobulin (IVIg) is an adjunctive therapy for juvenile dermatomyositis (JDM) patients with poor response to first-line therapy (corticosteroid resistant; SR) or who are ...